Skip to content

Validation of clinical applicable techniques for end inspiratory lung volume (Vei) measurement.

Validation of clinical applicable techniques for end inspiratory lung volume (Vei) measurement. - Vei measurement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42776
Enrollment
20
Registered
2015-09-23
Start date
2015-11-18
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hyperinflation too high lung volume

Interventions

None listed

Sponsors

Intensive Care
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - severe airway obstruction due to obstructive airway diseases ( COPD and asthma) - controlled mechanical ventilation - deep sedation - arterial catheter

Exclusion criteria

Exclusion criteria: - hypoxemic failure (FiO2 > 70%) - presence of pneumothorax

Design outcomes

Primary

MeasureTime frame
The primary study parameter is the difference in degree of pulmonary hyperinflation, expressed as the volume at end inspiration (Vei) between the gold standard and formula (Vei_measurement versus Vei_formula) and between the gold standard and the ventilator (Vei_measurement versus Vei_ventilator).

Secondary

MeasureTime frame
Other study parameters are based on clinical outcome of patients, such as incidence of pneumothorax, days on the ventilator and need for vasopressors.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)